{
  "documents": [
    {
      "id": "cluster_23_doc1",
      "content": "Arizona Horizon Health reported an unusual cluster of idiopathic cardiomyopathy cases linked to genetic markers in individuals of Polynesian descent. Patient ID# PX-88723 was admitted on 06/15/2023 for advanced cardiac monitoring. Treatment included a tailored regimen of sacubitril/valsartan and ongoing genetic counseling. Dr. Elena Varga noted the patient's participation in study NCT04567823 exploring familial cardiomyopathy patterns. Address on file: 2301 W. Catalina Dr., Phoenix, AZ 85029.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_23_doc2",
      "content": "Notification: Policy revision #PHX-CARD-2023-09 effective October 1 mandates pre-authorization for advanced genetic testing related to cardiomyopathies. Impacted members include those with ICD-10 codes I42.8-I42.9 and participant IDs beginning with PX. Provider queries should be directed to geneticcounseling@azhh.com or (602) 555-0172. Processing times may increase during transition period.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_23_doc3",
      "content": "Community Health Digest (09/10/2023): Phoenix cardiology practices see 37% increase in genetic testing volumes since January. Arizona Horizon Health's research division published interim findings from NCT04567823, showing 58% of participants with RBM20 variants required hospitalization within 12 months. Outreach events scheduled at Papago Cultural Center through Q4.",
      "metadata": {
        "format": "news_article"
      }
    },
    {
      "id": "cluster_23_doc4",
      "content": "Claim #89022-331: 11/02/2023 echocardiogram and genetic panel for PX-88723 (DOB 04/19/1985) processed with partial denial. Code Z13.6 requires additional documentation per policy PHX-CARD-2023-09. Patient responsibility: $340. Coordinator notes indicate follow-up with Dr. Varga's office requested regarding variant interpretation.",
      "metadata": {
        "format": "claim_form"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_23",
    "cluster_risk": "HIGH",
    "content_summary": "Complex case linking genetic cardiomyopathy research, policy changes, and individual patient journey through Arizona Horizon Health system",
    "person": {
      "entities": [
        [
          "PX-88723",
          "PATIENT_ID"
        ],
        [
          "06/15/2023",
          "EVENT_DATE"
        ],
        [
          "11/02/2023",
          "EVENT_DATE"
        ],
        [
          "sacubitril/valsartan",
          "TREATMENT"
        ],
        [
          "ongoing genetic counseling",
          "TREATMENT"
        ],
        [
          "advanced cardiac monitoring",
          "TREATMENT"
        ],
        [
          "advanced genetic testing",
          "TREATMENT"
        ],
        [
          "genetic panel",
          "TREATMENT"
        ],
        [
          "echocardiogram",
          "TREATMENT"
        ],
        [
          "2301 W. Catalina Dr., Phoenix, AZ 85029",
          "ADDRESS"
        ],
        [
          "04/19/1985",
          "BIRTHDATE"
        ],
        [
          "Polynesian",
          "DEMOGRAPHIC"
        ],
        [
          "idiopathic cardiomyopathy",
          "MEDICAL_CONDITION"
        ],
        [
          "RBM20",
          "UNIQUE_FACT"
        ]
      ]
    },
    "questions": [
      {
        "q": "What treatment combination and research study involved patient PX-88723 with idiopathic cardiomyopathy?",
        "a": "Sacubitril/valsartan regimen and study NCT04567823 on familial patterns.",
        "sources": [
          "cluster_23_doc1"
        ],
        "type": "specific"
      },
      {
        "q": "What new pre-authorization requirement took effect for Phoenix cardiomyopathy patients in October 2023?",
        "a": "Policy PHX-CARD-2023-09 mandates approval for advanced genetic testing.",
        "sources": [
          "cluster_23_doc2"
        ],
        "type": "general"
      },
      {
        "q": "What genetic variant and clinical outcome were reported for participant PX-88723 in the Arizona Horizon Health study?",
        "a": "RBM20 variant with 58% hospitalization risk within 12 months.",
        "sources": [
          "cluster_23_doc1",
          "cluster_23_doc3"
        ],
        "type": "specific"
      },
      {
        "q": "How did policy changes impact genetic testing volumes and claim processing for cardiology patients?",
        "a": "37% testing increase and partial denials requiring additional documentation.",
        "sources": [
          "cluster_23_doc2",
          "cluster_23_doc3",
          "cluster_23_doc4"
        ],
        "type": "general"
      }
    ]
  }
}